Health

Results: 5653-5664 of 8177

PR Newswire associated0

Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024

PR Newswire associated0

Eve Communications, Inc. to Showcase at What's Next Longevity Venture Summit June 11-12, 2024 in San Francisco, California.

PR Newswire associated0

Endo Launches New Dupuytren's Contracture Campaign: Reminders

Professor Jean-Jacques Kiladjian, University of Paris, France Photo credit: AOP Health/Lorenz Paulus

Hematology/Oncology: AOP Health’s Expanding Clinical Research Program Delivers New Results

ACCESSWIRE associated0

AGFA HealthCare Secures Major New Deal With Alliance Medical for a Comprehensive Cloud-Based Enterprise Imaging Solution Across the UK

PR Newswire associated0

India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad

Nagase Viita Launches SOLBIOTE (TM), New Brand of Injectable-grade Saccharide Excipients for Biopharmaceuticals

PR Newswire associated0

J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study

(Graphic: Business Wire)

4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients

FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer's Disease

PR Newswire associated0

Calyx / Invicro Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of Radioligand Therapies and Immuno-Oncology Agents

Business Wire logo

Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®